On Cancer

Filter by Tag

In the Clinic

New Drug Shows Promise for Patients with Advanced Kidney Cancer

By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

Tags: Cancer Care; Research; Clinical Research; Clinical Trials; Targeted Therapy; Kidney Cancer

In the Clinic

New Treatment Option for People with Advanced Kidney Cancer

By Esther Napolitano, BS, Science Writer/Editor | Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Tags: Research; Targeted Therapy; Kidney Cancer

In the News

Memorial Sloan-Kettering Made Major Contributions to Cancer Advances in 2011

By Julie Grisham, MS, Science Writer/Editor | Monday, February 6, 2012

Two of the year’s top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan-Kettering investigators.

Tags: Cancer Care; Research; Personalized Medicine; Targeted Therapy; Melanoma; Ovarian Cancer; Prostate Cancer

Pictured: Charles Sawyers & Howard Scher

In the News

New Medical Strides against Prostate Cancer

By Media Staff | Friday, February 3, 2012

The success of an experimental prostate cancer treatment is an example of how academic research centers are playing a larger role in drug development, the Wall Street Journal reports.

Tags: Research; Drug Discovery; Targeted Therapy; Prostate Cancer

In the Clinic

New Strategy Shows Promise for Treating Nasopharyngeal Cancer

By Eva Kiesler, PhD, Science Writer/Editor | Monday, December 19, 2011

People with cancer of the nasopharynx, an area behind the nose, may benefit from a new combination therapy, according to an international study led by Memorial Sloan-Kettering radiation oncologist Nancy Y. Lee.

Tags: Cancer Care; Research; Targeted Therapy; Head & Neck Cancers

In the Lab

Researchers Discover Why New Melanoma Drug Stops Working

By Media Staff | Wednesday, November 23, 2011

Research led by investigators at Memorial Sloan-Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

Tags: Research; Drug Discovery; Targeted Therapy; Melanoma